Liabilities and Equity of BIO-PATH HOLDINGS, INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
BIO-PATH HOLDINGS, INC. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • BIO-PATH HOLDINGS, INC. Liabilities and Equity for the quarter ending 30 Sep 2025 was $690,000, a 77% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

BIO-PATH HOLDINGS, INC. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $690,000 -$2,275,000 -77% 30 Sep 2025 10-Q 13 Jan 2026 2025 Q3
Q2 2025 $746,000 -$4,372,000 -85% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $2,195,000 +$427,000 +24% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $3,883,000 +$663,000 +21% 31 Dec 2024 10-Q 13 Jan 2026 2025 Q3
Q3 2024 $2,965,000 -$2,056,000 -41% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $5,118,000 -$1,406,000 -22% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,768,000 -$9,334,000 -84% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $3,220,000 -$12,751,000 -80% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $5,021,000 -$13,518,000 -73% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $6,524,000 -$14,485,000 -69% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $11,102,000 -$12,976,000 -54% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $15,971,000 -$10,597,000 -40% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $18,539,000 -$12,141,000 -40% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $21,009,000 -$10,118,000 -33% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $24,078,000 -$9,021,000 -27% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $26,568,000 +$10,093,000 +61% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $30,680,000 +$15,807,000 +106% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $31,127,000 +$13,607,000 +78% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $33,099,000 +$13,273,000 +67% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $16,475,000 -$6,185,000 -27% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $14,873,000 -$2,722,000 -15% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $17,520,000 -$1,799,000 -9.3% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $19,826,000 -$1,493,000 -7% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $22,660,000 +$20,115,000 +790% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $17,595,000 +$13,650,000 +346% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $19,319,000 +$13,577,000 +236% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $21,319,000 +$14,115,000 +196% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $2,545,000 -$6,313,000 -71% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $3,945,000 -$3,371,000 -46% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $5,742,000 -$3,689,000 -39% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $7,204,000 -$2,907,000 -29% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $8,858,000 -$3,338,000 -27% 31 Dec 2017 10-K 19 Mar 2019 2018 FY
Q3 2017 $7,316,000 -$6,126,000 -46% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $9,431,000 +$2,291,000 +32% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $10,111,000 +$1,165,000 +13% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $12,196,000 +$1,441,000 +13% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $13,442,000 +$1,769,335 +15% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $7,140,000 -$6,152,596 -46% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $8,946,000 -$5,302,879 -37% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $10,755,000 -$4,722,978 -31% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $11,672,665 -$4,611,854 -28% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $13,292,596 -$4,072,646 -23% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $14,248,879 -$4,348,786 -23% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $15,477,978 +$10,399,147 +205% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 $16,284,519 +$10,533,990 +183% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 $17,365,242 +$13,620,595 +364% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $18,597,665 +$16,627,047 +844% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $5,078,831 +$2,735,067 +117% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $5,750,529 +$3,680,473 +178% 30 Sep 2013 10-Q/A 18 Nov 2013 2013 Q3
Q2 2013 $3,744,647 +$1,579,439 +73% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 $1,970,618 -$737,840 -27% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 $2,343,764 -$887,341 -27% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $2,070,056 -$1,334,381 -39% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $2,165,208 -$1,498,740 -41% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 $2,708,458 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 $3,231,105 +$122,601 +3.9% 31 Dec 2011 10-K 01 Apr 2013 2012 FY
Q3 2011 $3,404,437 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $3,663,948 30 Jun 2011 10-Q/A 29 Aug 2011 2011 Q2
Q4 2010 $3,108,504 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.